Overall rank by patents
#4,246
of 49,997 tracked assignees
USPTO PatentsView assignee record - 84 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Inovio ranks #4,246 of 49,997 tracked US assignees by granted-patent volume, with 84 patents across 18 technology areas.
USPTO PatentsView assignee plate
Corpus R4246 · US Corporation #4,246 · 84 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Galapagos NV (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
American Honda Motor · near
50 score
Bourns · near
50 score
GIESECKE+DEVRIENT… · near
50 score
Inovio Pharmaceuticals · this assignee
50 score
Spiber · near
50 score
3D Lighting… · lowest
7 score
What this shows Inovio's Innovation Score is 50.1/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Inovio Pharmaceuticals, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 83.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (17 grants) versus a trough of 1 in 2017. By volume, Inovio sits between Galapagos NV and Mallinckrodt Hospital Products IP Unlimited Company.
From 2019–2021 to 2022–2024, Inovio Pharmaceuticals, Inc. moved from 25 to 38 grants (1.52x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Galapagos NV
84 patents
Ignite USA, LLC
84 patents
Imra America, Inc.
84 patents
Inmar Clearing, Inc.
84 patents
Jtekt Europe
84 patents
Kitagawa Industries Co., Ltd.
84 patents
M. Technique Co., Ltd.
84 patents
Mallinckrodt Hospital Products IP Unlimited Company
84 patents
Inovio Pharmaceuticals, Inc.
84 patents
What this shows Inovio holds 84 patents at rank #4,246, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,246 in granted patent volume.
Other assignees with the most granted patents in Inovio's primary technology class.
Two PlainPatent-derived peer sets for Inovio, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (50 here).
Nearest assignees by average claims per patent (16.0 here).
Inovio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 14% higher than 86% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 6.0% |
| 2016 | 3 | 3.6% |
| 2017 | 1 | 1.2% |
| 2018 | 7 | 8.3% |
| 2019 | 5 | 6.0% |
| 2020 | 3 | 3.6% |
| 2021 | 17 | 20.2% |
| 2022 | 10 | 11.9% |
| 2023 | 12 | 14.3% |
| 2024 | 16 | 19.0% |
| 2025partial year | 5 | 6.0% |
Top 15 of 18 technology areas
Overall rank by patents
#4,246
of 49,997 tracked assignees
50.1 out of 100
What to do with this data
Inovio Pharmaceuticals, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.